Stay updated on Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with a minimal header and a Home button. This replaces the previously visible study record content and related information on the page.
    Difference
    20%
    Check dated 2026-09-19T19:05:42.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.5 to v3.6.6, reflecting an incremental update to the page’s content/template managed by the site. This change signals a maintenance update and does not modify the study data or key details presented on the page.
    Difference
    0.1%
    Check dated 2026-08-29T19:16:41.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    The page now displays a new revision tag, v3.6.5, replacing the previous v3.6.4 revision tag.
    Difference
    0.0%
    Check dated 2026-08-08T17:02:02.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.6.3 to v3.6.4, indicating a small version update to the page/template. This reflects a backend/content management update rather than a user-facing content change.
    Difference
    0.0%
    Check dated 2026-07-25T07:47:07.000Z thumbnail image
  7. Check
    95 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.2 to v3.6.3, indicating a software/content management update. The study details and visible content appear unchanged.
    Difference
    0.0%
    Check dated 2026-07-03T22:21:04.000Z thumbnail image
  8. Check
    102 days ago
    Change Detected
    Summary
    The page revision metadata was updated from v3.6.0 to v3.6.2, indicating a newer version of the page. This update represents a minor documentation revision and does not alter study details, eligibility criteria, or outcomes.
    Difference
    0.0%
    Check dated 2026-06-27T00:02:01.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial page.